Senate Finance Advances Tom Price HHS Confirmation, Sans Democrats
An all-Republican Senate Finance panel changed the committee’s rules Feb. 1 and voted 14-0 to advance HHS Secretary nominee Tom Price’s, R-Ga., confirmation to the full Senate, after the panel’s Democrats, led by ranking member Ron Wyden of Oregon, boycotted Price’s confirmation markup for a second day due to lingering questions about Price’s investments in Innate Immunotherapeutics stocks, Wyden said.
You may also be interested in...
The House Energy and Commerce Committee Democrat says few in-depth member talks about user-fee bills have taken place because of a focus on Affordable Care Act repeal and replacement.
Senate Finance Committee Ranking Member Ron Wyden led other panel Democrats in boycotting a planned Jan. 31 vote on the confirmation of Rep. Tom Price as HHS Secretary. Wyden said the nominee "misled the public" and held back information on discounted shares of an Australian biomedical firm he bought. Committee Chair Orrin Hatch, R-Utah, was surprised by the setback to President Trump's nominee, and swore to bring Senate Democrats back to the committee to "do their job.”
The White House will be spending $86m to provide tens of millions of coronavirus masks to poorer American households.